CS
AZN icon

Cannell & Spears’s AstraZeneca AZN Stock Holding History

Cannell & Spears’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$316K Hold
1,666
– – 0.01% 364
2026
Q1 		$329K Sell
1,666
-1
-0.1% -$193 0.01% 348
2025
Q4 		$306K Hold
1,667
– – 0.01% 341
2025
Q3 		$256K Buy
1,667
+176
+12% +$26.6K ﹤0.01% 361
2025
Q2 		$208K Buy
1,491
+11
+0.7% +$1.54K ﹤0.01% 367
2025
Q1 		$218K Buy
+1,480
New +$214K ﹤0.01% 357
2024
Q4 		– Sell
-2,063
Closed -$321K – 397
2024
Q3 		$321K Buy
2,063
+408
+25% +$65.9K 0.01% 334
2024
Q2 		$258K Hold
1,655
– – 0.01% 319
2024
Q1 		$224K Hold
1,655
– – ﹤0.01% 351
2023
Q4 		$223K Hold
1,655
– – 0.02% 198
2023
Q3 		$224K Hold
1,655
– – 0.02% 188
2023
Q2 		$237K Hold
1,655
– – 0.02% 200
2023
Q1 		$230K Hold
1,655
– – 0.02% 204
2022
Q4 		$224K Buy
+1,655
New +$208K 0.02% 203
2022
Q3 		– Sell
-1,655
Closed -$219K – 194
2022
Q2 		$219K Hold
1,655
– – 0.02% 189
2022
Q1 		$220K Buy
+1,655
New +$198K 0.02% 211
2015
Q3 		– Sell
-3,656
Closed -$233K – 133
2015
Q2 		$233K Buy
3,656
+28
+0.8% +$1.92K 0.03% 129
2015
Q1 		$248K Buy
+3,628
New +$252K 0.03% 121

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Cannell & Spears's AZN Position: Q2 2026 in Review

Cannell & Spears held its AstraZeneca (AZN) position steady in Q2 2026 at 1,666 shares worth $316K. The position accounts for 0.01% of the portfolio, ranked #364.

Cannell & Spears first reported a position in AZN in Q1 2015 and has held it in 18 quarters since. The position peaked at $329K in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Cannell & Spears held 1,666 shares of AstraZeneca worth $316K as of Q2 2026.
  • Cannell & Spears left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 0.01% of Cannell & Spears's portfolio in Q2 2026, its #364 holding.
  • Cannell & Spears first reported a position in AstraZeneca in Q1 2015 and has held it in 18 quarters since.
  • Cannell & Spears's AstraZeneca position peaked at $329K in Q1 2026.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Cannell & Spears's 13F filing for Q2 2026, filed 11 Aug 2026.